throbber

`
`
`Filed on behalf of: Acrux DDS PTY LTD.
`
`
`
`Acrux Limited
`
`
`By: E. Anthony Figg, Reg. No. 27,195
`
`Aydin H. Harston, Reg. No. 65,249
`
`ROTHWELL, FIGG, ERNST & MANBECK, P.C.
`
`607 14th St., N.W., Suite 800
`
`
`Washington, DC 20005
`Phone: 202-783-6040;
`Fax: 202-783-6031
`Emails: efigg@rothwellfigg.com
`
` aharston@rothwellfigg.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`Paper _____
`
`Filed: August 8, 2017
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`
`ACRUX DDS PTY LTD. & ACRUX LIMITED,
`Petitioners,
`
`v.
`
`KAKEN PHARMACEUTICAL CO., LTD. and
`VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
`Patent Owner and Licensee.
`_______________
`
`Case IPR2017-00190
`Patent No. 7,214,506
`_______________
`
`PETITIONERS’ OBJECTIONS TO EVIDENCE SUBMITTED WITH
`PATENT OWNER’S RESPONSE
`PURSUANT TO 37 C.F.R. § 42.64(b)(1)
`
`
`

`

`
`

`

`Pursuant to 37 C.F.R. § 42.64(b)(1), Acrux DDS PTY Ltd. and Acrux
`
`Case IPR2017-00190
`

`
`
`Limited (collectively, “Petitioners”) hereby object to the admissibility of the
`
`following evidence submitted by Kaken Pharmaceutical Co., Ltd. and Valeant
`
`Pharmaceuticals International, Inc. (collectively, “Patent Owners”) with the Patent
`
`Owners’ Response (Paper No. 27) (“POR”).1
`
`Evidence Submitted by
`Patent Owners
`Exhibits 2001/20032
`(Declaration of Yochiyuki
`Tatsumi, Ph.D.)
`
`Petitioners’ Objection(s)
`
`Inadmissible as lacking foundation, assuming facts
`not in evidence, conclusory, and containing
`testimony concerning Exhibit 2004 for which
`authentication is lacking.
`
`Paragraph 8 is inadmissible as irrelevant (Fed. R.
`Evid. 402) to the extent it is not directed to the
`claimed subject matter and/or the prior art cited in
`the grounds on which the review was instituted.
`
`Paragraphs 9 through 12 are inadmissible as there
`is no indication that the declarant has personal
`knowledge of the alleged experiments described
`therein (Fed. R. Evid. 602) and as hearsay to the
`extent the testimony is being used to prove the
`truth of the matters asserted (Fed. R. Evid. 802).
`
`                                                            
`1 Petitioners have reasserted their Objections to Evidence Submitted with Patent
`
`Owners’ Preliminary Response (“POPR”) to preserve them.
`
`2 Petitioners list both exhibit numbers with respect to objections directed to the
`
`original Japanese language document and the corresponding English translation
`
`offered by Patent Owners.
`

`
`2
`
`

`


`
`Evidence Submitted by
`Patent Owners
`
`Exhibits 2002/20043
`
`Case IPR2017-00190
`
`Petitioners’ Objection(s)
`
`To the extent Patent Owners are introducing Dr.
`Tatsumi’s testimony as expert opinion, it is
`unsupported by sufficient facts or data (Fed. R.
`Evid. 702). See, e.g., POPR, at 19.
`Inadmissible as incomplete (Fed. R. Evid. 106) as
`it sets forth summaries of data allegedly obtained
`while not presenting all of the data obtained and its
`full underlying information in fairness to allow
`Petitioners to test its validity.
`
`Inadmissible as hearsay (Fed. R. Evid. 802) to the
`extent the document is being used to prove the
`truth of the matters asserted.
`
`Inadmissible as lacking authentication (Fed. R.
`Evid. 901). Patent Owner’s declarant Dr. Tatsumi
`(Exhibit 2001/2003) does not provide sufficient
`
`                                                            
`3 Although it appears Patent Owners have provided a “Corrected Research and
`
`Development Report” (Exhibit 2040, with corresponding Japanese language
`
`document at Exhibit 2039) Patent Owners have not specified what was corrected
`
`from the version filed previously as Exhibit 2004. Further, the POR cites to
`
`Exhibit 2004 and Dr. Tatsumi’s Declaration in Support of the POR cites to Exhibit
`
`2039. Compare POR, at 41 to Ex. 2025, at ¶¶ 14-15. To the extent Patent Owners
`
`have filed any exhibit in support of the POR in an attempt to cure the timely
`
`objections asserted in Petitioner’s Objections to Evidence Submitted with the
`
`POPR, filed on May 15, 2017, they are untimely as supplemental evidence was due
`
`by or before May 30, 2017. 37 C.F.R. § 42.64(b)(2).
`

`
`3
`
`

`


`
`Evidence Submitted by
`Patent Owners
`
`Exhibits 2007, 2008, 2009,
`2010
`
`Exhibit 2011
`
`Exhibits 2012, 2013, 2014,
`2015, 2016, 2017
`
`Case IPR2017-00190
`
`Petitioners’ Objection(s)
`
`evidence to establish that Exhibit 2004 is self-
`authenticating under Fed. R. Evid. 902 because
`there is no evidence presented to support his
`conclusory assertions tracking the requirements of
`FRE 803(6)(A)-(C).
`Inadmissible as unsupported expert testimony
`(Fed. R. Evid. 702). See, e.g., POR, at 9-10, 13-16,
`25-30.
`
`Inadmissible as hearsay (Fed. R. Evid. 802) to the
`extent the documents are being used to prove the
`truth of the matters asserted therein. See, e.g.,
`POR, at 9-10, 13-16, 25-30.
`Inadmissible as unsupported expert testimony
`(Fed. R. Evid. 702). See, e.g., POR, at 15, 25.
`
`Inadmissible as hearsay (Fed. R. Evid. 802) to the
`extent the document is being used to prove the
`truth of the matters asserted therein. See, e.g.,
`POR, at 15, 25.
`
`Inadmissible as lacking authentication (Fed. R.
`Evid. 901) as there is no indication of source
`accompanying the document, no witness testimony
`is offered to indicate its source and books are not
`self-authenticating under FRE 902.
`Inadmissible as unsupported expert testimony
`(Fed. R. Evid. 702). See, e.g., POR, at 11-13, 15-
`16, 23.
`
`Inadmissible as hearsay (Fed. R. Evid. 802) to the
`extent the documents are being used to prove the
`truth of the matters asserted therein. See, e.g.,
`POR, at 11-13, 15-16, 23.
`

`
`4
`
`

`


`
`Evidence Submitted by
`Patent Owners
`Exhibit 2018
`
`Exhibits 2024/2025
`(Declaration of Yochiyuki
`Tatsumi, Ph.D.)
`

`
`Case IPR2017-00190
`
`Petitioners’ Objection(s)
`
`Inadmissible as unsupported expert testimony
`(Fed. R. Evid. 702). See, e.g., POR, at 23-24.
`
`Inadmissible as hearsay (Fed. R. Evid. 802) to the
`extent the document is being used to prove the
`truth of the matters asserted therein. See, e.g.,
`POR, at 23-24.
`
`Inadmissible as lacking authentication (Fed. R.
`Evid. 901) as there is no indication of source
`accompanying the document, no witness testimony
`is offered to indicate its source and articles
`retrieved from the internet are not self-
`authenticating under FRE 902.
`Inadmissible as lacking foundation, assuming facts
`not in evidence, conclusory, and containing
`testimony concerning several exhibits for which
`authentication is lacking.
`
`Paragraph 8 is inadmissible as there is no
`indication that the declarant has personal
`knowledge of the alleged experiments described
`therein (Fed. R. Evid. 602) and as hearsay to the
`extent the testimony is being used to prove the
`truth of the matters asserted (Fed. R. Evid. 802).
`
`Paragraphs 9, 10 and 13 are submitted in violation
`of 37 C.F.R. § 1.933. The information set forth in
`these paragraphs, as well as the Patent Owner’s
`exhibits cited therein, should have been submitted
`both during prosecution of the ’506 patent and
`earlier in this proceeding, e.g., in connection with
`Dr. Tatsumi’s Declaration submitted in support of
`the Patent Owner’s Preliminary Response (Exhibit
`2001/2003).
`
`Paragraph 17 is inadmissible as irrelevant (Fed. R.
`Evid. 402) to the extent it is not directed to the
`5
`
`

`


`
`Evidence Submitted by
`Patent Owners
`
`Exhibit 2027
`(Declaration of Boni E.
`Elewski, M.D.)
`

`
`Case IPR2017-00190
`
`Petitioners’ Objection(s)
`
`claimed subject matter and/or the prior art cited in
`the grounds on which the review was instituted.
`
`Paragraphs 14 through 16 and 18 through 21 are
`inadmissible as there is no indication that the
`declarant has personal knowledge of the alleged
`experiments described therein (Fed. R. Evid. 602)
`and as hearsay to the extent the testimony is being
`used to prove the truth of the matters asserted
`(Fed. R. Evid. 802). To the extent Patent Owners
`are introducing Dr. Tatsumi’s testimony as expert
`opinion, it is unsupported by sufficient facts or
`data (Fed. R. Evid. 702). See, e.g., POR, at 37, 44.
`
`To the extent a portion or portions of the
`Declaration of Yochiyuki Tatsumi, Ph.D. (or the
`exhibits cited and discussed therein) are being
`offered to cure Petitioners’ timely Objections to
`Evidence Submitted with the POPR, filed on May
`15, 2017, they are inadmissible as untimely. In
`order to address those objections, Patent Owners
`were required to submit supplemental evidence by
`or before May 30, 2017 which they failed to do.
`37 C.F.R. § 42.64(b)(2).
`Inadmissible as lacking foundation, assuming facts
`not in evidence, conclusory, unsupported by
`sufficient facts or data (Fed. R. Evid. 702), and
`containing testimony concerning several exhibits
`for which authentication is lacking.
`
`To the extent a portion or portions of the
`Declaration of Boni E. Elewski, M.D. (or the
`exhibits cited and discussed therein) are being
`offered to cure Petitioners’ timely Objections to
`Evidence Submitted with the POPR, filed on May
`15, 2017, they are inadmissible as untimely. In
`order to address those objections, Patent Owners
`were required to submit supplemental evidence by
`6
`
`

`


`
`Evidence Submitted by
`Patent Owners
`
`Exhibit 2028
`(Declaration of Vince
`Thomas)
`
`Exhibits 2030/2031
`
`Exhibits 2033/2034
`

`
`Case IPR2017-00190
`
`Petitioners’ Objection(s)
`
`or before May 30, 2017 which they failed to do.
`37 C.F.R. § 42.64(b)(2).
`Inadmissible as lacking foundation, assuming facts
`not in evidence, conclusory, unsupported by
`sufficient facts or data (Fed. R. Evid. 702), and
`containing testimony concerning several exhibits
`for which authentication is lacking.
`Inadmissible as hearsay (Fed. R. Evid. 802) to the
`extent the document is being used to prove the
`truth of the matters asserted.
`
`Inadmissible as lacking authentication (Fed. R.
`Evid. 901). Patent Owner’s declarant Dr. Tatsumi
`(Exhibit 2024/2025) does not provide sufficient
`evidence to establish that these exhibits are self-
`authenticating under Fed. R. Evid. 902 because
`there is no evidence presented to support his
`conclusory assertions tracking the requirements of
`FRE 803(6)(A)-(C).
`Inadmissible as incomplete (Fed. R. Evid. 106) as
`the exhibit sets forth tables of mean data allegedly
`obtained while not presenting its full underlying
`information (e.g., the experimental protocol used
`to obtain the data, laboratory notebook pages, etc.)
`in fairness to allow Petitioners to test its validity.
`
`Inadmissible as hearsay (Fed. R. Evid. 802) to the
`extent the document is being used to prove the
`truth of the matters asserted.
`
`Inadmissible as lacking authentication (Fed. R.
`Evid. 901). Patent Owner’s declarant Dr. Tatsumi
`(Exhibit 2024/2025) does not provide sufficient
`evidence to establish that these exhibits are self-
`authenticating under Fed. R. Evid. 902 because
`there is no evidence presented to support his
`conclusory assertions tracking the requirements of
`FRE 803(6)(A)-(C).
`7
`
`

`


`
`Evidence Submitted by
`Patent Owners
`Exhibits 2036, 2037, 2038
`
`Exhibits 2039/2040,
`2042/2043, 2045/2046
`

`
`Case IPR2017-00190
`
`Petitioners’ Objection(s)
`
`Inadmissible as incomplete (Fed. R. Evid. 106) as
`they set forth tables of mean data allegedly
`obtained while not presenting the full underlying
`information in fairness to allow Petitioners to test
`its validity.
`
`Inadmissible as hearsay (Fed. R. Evid. 802) to the
`extent the documents are being used to prove the
`truth of the matters asserted.
`
`Inadmissible as lacking authentication (Fed. R.
`Evid. 901). Patent Owner’s declarant Dr. Tatsumi
`(Exhibit 2024/2025) states that the exhibits were
`located in his “corporate files” (see Exhibit 2025, ¶
`9), however, that testimony is contradicted by the
`stamp on each exhibit’s cover which appears to
`indicate that it was obtained from the University of
`California Los Angeles Biomedical Library.
`
`Submitted in violation of 37 C.F.R. § 1.933.
`These exhibits and the information relating to
`them set forth in Dr. Tatsumi’s Declaration
`submitted in support of the POR (Exhibit
`2024/2025) should have been submitted both
`during prosecution of the ’506 patent and earlier in
`this proceeding, e.g., in connection with Dr.
`Tatsumi’s Declaration submitted in support of the
`Patent Owner’s Preliminary Response (Exhibit
`2001/2003).
`Inadmissible as incomplete (Fed. R. Evid. 106) as
`these exhibits set forth summaries of data
`allegedly obtained while not presenting its full
`underlying information in fairness to allow
`Petitioners to test its validity.
`
`Inadmissible as hearsay (Fed. R. Evid. 802) to the
`extent the documents are being used to prove the
`truth of the matters asserted.
`8
`
`

`


`
`Evidence Submitted by
`Patent Owners
`
`Exhibit 2053
`
`Exhibit 2054
`
`Exhibits 2055, 2056, 2069,
`2070, 2072
`

`
`Case IPR2017-00190
`
`Petitioners’ Objection(s)
`
`Inadmissible as lacking authentication (Fed. R.
`Evid. 901). Patent Owner’s declarant Dr. Tatsumi
`(Exhibit 2024/2025) does not provide sufficient
`evidence to establish that these exhibits are self-
`authenticating under Fed. R. Evid. 902 because
`there is no evidence presented to support his
`conclusory assertions tracking the requirements of
`FRE 803(6)(A)-(C).
`
`To the extent these exhibits are being offered to
`cure Petitioners’ timely Objections to Evidence
`Submitted with the POPR, filed on May 15, 2017,
`they are inadmissible as untimely. In order to
`address those objections, Patent Owners were
`required to submit supplemental evidence by or
`before May 30, 2017 which they failed to do. 37
`C.F.R. § 42.64(b)(2).
`Inadmissible as incomplete (Fed. R. Evid. 106) as
`the exhibit is missing pages 1 and 2.
`
`Inadmissible as lacking authentication (Fed. R.
`Evid. 901) as there is no indication of source
`accompanying the document and no witness
`testimony is offered to indicate its source.
`Inadmissible as unsupported expert testimony
`(Fed. R. Evid. 702). See, e.g., POR, at 23.
`
`Inadmissible as hearsay (Fed. R. Evid. 802) to the
`extent the document is being used to prove the
`truth of the matters asserted.
`
`Inadmissible as lacking authentication (Fed. R.
`Evid. 901) as there is no indication of source
`accompanying the document and no witness
`testimony is offered to indicate its source.
`Inadmissible as lacking authentication (Fed. R.
`Evid. 901) as there is no indication of source
`accompanying the documents, no witness
`9
`
`

`


`
`Evidence Submitted by
`Patent Owners
`
`Exhibit 2058
`
`Exhibit 2059
`
`Exhibit 2060
`
`Exhibit 2063
`

`
`Case IPR2017-00190
`
`Petitioners’ Objection(s)
`
`testimony is offered to indicate their source and
`journals are not self-authenticating under FRE
`902.
`Inadmissible as hearsay (Fed. R. Evid. 802) to the
`extent the document is being used to prove the
`truth of the matters asserted.
`
`Inadmissible as lacking authentication (Fed. R.
`Evid. 901) as there is no indication of source
`accompanying the document, no witness testimony
`is offered to indicate its source and journals are not
`self-authenticating under FRE 902.
`Inadmissible as hearsay (Fed. R. Evid. 802) to the
`extent the document is being used to prove the
`truth of the matters asserted.
`
`Inadmissible as lacking authentication (Fed. R.
`Evid. 901) as there is no indication of source
`accompanying the document, no witness testimony
`is offered to indicate its source and articles
`retrieved from the internet are not self-
`authenticating under FRE 902.
`Inadmissible as irrelevant (Fed. R. Evid. 402) as
`the exhibit is not cited or referenced in either the
`POR or any supporting declaration. The citation
`to Exhibit 2060 in the Declaration of Vince
`Thomas (Exhibit 2028) is to a different document
`(an internet article which appears to differ in
`content from the Exhibit 2060 submitted by Patent
`Owners). See Exhibit 2028, ¶ 16.
`Inadmissible as incomplete (Fed. R. Evid. 106) as
`the exhibit appears to be missing multiple pages.
`
`Inadmissible as lacking authentication (Fed. R.
`Evid. 901) as there is no indication of source
`accompanying the document, no witness testimony
`is offered to indicate its source and articles
`retrieved from the internet are not self-
`10
`
`

`


`
`Evidence Submitted by
`Patent Owners
`
`Exhibits 2071, 2079, 2080,
`2081, 2085, 2090, 2091
`
`Exhibit 2086
`
`Exhibit 2087
`
`Exhibit 2088
`

`
`Case IPR2017-00190
`
`Petitioners’ Objection(s)
`
`authenticating under FRE 902.
`Inadmissible as lacking authentication (Fed. R.
`Evid. 901) as there is no indication of source
`accompanying the documents, no witness
`testimony is offered to indicate their source and
`articles retrieved from the internet are not self-
`authenticating under FRE 902.
`Inadmissible as incomplete (Fed. R. Evid. 106) as
`the exhibit is an abstract of a 36 page article and
`Petitioners should be provided with the full article
`for context.
`
`Inadmissible as lacking authentication (Fed. R.
`Evid. 901) as there is no indication of source
`accompanying the document, no witness testimony
`is offered to indicate its source and articles
`retrieved from the internet are not self-
`authenticating under FRE 902.
`Inadmissible as irrelevant (Fed. R. Evid. 402) as
`the exhibit is not cited or referenced in either the
`POR or any supporting declaration.
`
`Inadmissible as lacking authentication (Fed. R.
`Evid. 901) as there is no indication of source
`accompanying the document, no witness testimony
`is offered to indicate its source and articles
`retrieved from the internet are not self-
`authenticating under FRE 902.
`Inadmissible as incomplete (Fed. R. Evid. 106) as
`the text at the bottom of page 1 is cut off by an
`advertisement, it appears that the full website
`content has not been provided, and Petitioners
`should be provided with the full website for
`context.
`
`Inadmissible as lacking authentication (Fed. R.
`Evid. 901) as there is no indication of source
`accompanying the document, no witness testimony
`11
`
`

`


`
`Evidence Submitted by
`Patent Owners
`
`Exhibits 2093, 2094, 2095
`
`Exhibit 2097 (and Appendix
`A and B thereto)
`
`Exhibits 2098, 2099
`

`
`Case IPR2017-00190
`
`Petitioners’ Objection(s)
`
`is offered to indicate its source and articles
`retrieved from the internet are not self-
`authenticating under FRE 902.
`Inadmissible as incomplete (Fed. R. Evid. 106) as
`the exhibits provide partial information, since,
`inter alia, the referenced spreadsheets and/or
`alleged source data are either not identified or not
`provided and there is no information provided as
`to how the data used to prepare the exhibit was
`collected. This information is necessary such that,
`in fairness, Petitioners may test the sufficiency of
`the summary information provided.
`
`Inadmissible as irrelevant (Fed. R. Evid. 402) as
`the exhibits are not cited or referenced in either the
`POR or any supporting declaration.
`
`Inadmissible as hearsay (Fed. R. Evid. 802) to the
`extent the documents are being used to prove the
`truth of the matters asserted.
`
`Inadmissible as lacking authentication (Fed. R.
`Evid. 901) as there is no indication of source
`accompanying much of the information provided
`in the exhibits and no witness testimony is offered
`to explain the source(s) of the information.
`Inadmissible as untimely. The Declaration of
`Ashley Winkler and the accompanying appendices
`appear to be offered to cure Petitioners’ timely
`Objections to Evidence Submitted with the POPR,
`filed on May 15, 2017. In order to address those
`objections, Patent Owners were required to submit
`supplemental evidence by or before May 30, 2017
`which they failed to do. 37 C.F.R. § 42.64(b)(2).
`Inadmissible as incomplete (Fed. R. Evid. 106) as
`the exhibits provide partial information, since,
`inter alia, the referenced spreadsheets and/or
`alleged source data are either not identified or not
`12
`
`

`

`Evidence Submitted by
`Patent Owners
`
`Case IPR2017-00190
`
`Petitioners’ Objection(s)
`
`provided and there is no information provided as
`to how the data used to prepare the exhibit was
`collected. This information is necessary such that,
`in fairness, Petitioners may test the sufficiency of
`the summary information provided.
`
`Inadmissible as hearsay (Fed. R. Evid. 802) to the
`extent the documents are being used to prove the
`truth of the matters asserted.
`
`Inadmissible as lacking authentication (Fed. R.
`Evid. 901) as there is no indication of source
`accompanying much of the information provided
`in the exhibits and no witness testimony is offered
`to explain the source(s) of the information.
`
`
`The foregoing objections are made within 5 business days of service of the
`

`
`
`
`
`
`
`POR in accordance with 37 C.F.R. § 42.64(b)(1).
`
`
`
`
`
`
`
`
`
`Date: August 8, 2017
`
`
`
`
`
`
`
`
`
`
`
`

`
`
`
`Respectfully submitted,
`
`By:
`
`
`
`
`
`/s/ E. Anthony Figg
`E. Anthony Figg, Reg. No. 27,195
`Aydin H. Harston, Reg. No. 65,249
`ROTHWELL, FIGG, ERNST & MANBECK, P.C.
`607 14th St., N.W., Suite 800
`Washington, DC 20005
`Phone: 202-783-6040; Fax: 202-783-6031
`Counsel for Petitioners
`
`
`
`
`
`
`
`
`
`13
`
`

`

`Case IPR2017-00190
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that a copy of the foregoing PETITIONERS’
`

`
`
`
`OBJECTIONS TO EVIDENCE SUBMITTED WITH PATENT OWNER’S
`
`RESPONSE PURSUANT TO 37 C.F.R. § 42.64(b)(1) were served electronically
`
`via email on August 8, 2017, in its entirety on the following:
`
`John D. Livingstone
`john.livingstone@finnegan.com
`KakenIPR@finnegan.com
`Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
`271 17th Street, NW, Suite 1400
`Atlanta, GA 30363-6209
`
`Naoki Yoshida
`naoki.yoshida@finnegan.com
`Anthony Hartman
`anthony.hartmann@finnegan.com
`Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
`901 New York Ave., NW
`Washington, DC 20001-4413
`
`Toan P. Vo
`toan.vo@bausch.com
`Valeant Pharmaceuticals North America LLC
`1400 N. Goodman Street
`Rochester, New York 14609
`
`
`
`/s/ E. Anthony Figg
`
`By:
`E. Anthony Figg, Reg. No. 27,195
`Aydin H. Harston, Reg. No. 65,249
`ROTHWELL, FIGG, ERNST & MANBECK, P.C.
`607 14th St., N.W., Suite 800
`Washington, DC 20005
`Phone: 202-783-6040; Fax: 202-783-6031
`Counsel for Petitioners
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`
`
`
`
`
`
`
`
`
`
`14
`
`
`
`
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket